We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRTX
101
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$34.8M 0.23%
767,596
+105,095
+16% +$6.8M
WMS icon
102
Advanced Drainage Systems
WMS
$11B
$34.3M 0.23%
418,262
+107,488
+35% +$10.9M
PEP icon
103
PepsiCo
PEP
$191B
$34.2M 0.23%
189,526
-258,601
-58% -$46.1M
SEDG icon
104
SolarEdge
SEDG
$2.62B
$33.9M 0.23%
119,589
+7,968
+7% +$2.11M
TJX icon
105
TJX Companies
TJX
$173B
$33.8M 0.23%
424,214
+16,684
+4% +$1.23M
UPS icon
106
United Parcel Service
UPS
$96B
$33.7M 0.23%
193,869
-22,527
-10% -$3.9M
SLAB icon
107
Silicon Laboratories
SLAB
$7.17B
$33.3M 0.22%
245,374
-40,781
-14% -$5.36M
LULU icon
108
lululemon athletica
LULU
$13.4B
$33.1M 0.22%
103,458
+910
+0.9% +$299K
ENPH icon
109
Enphase Energy
ENPH
$5.01B
$32.3M 0.22%
121,878
+22,023
+22% +$6.41M
NBIX icon
110
Neurocrine Biosciences
NBIX
$17.7B
$32.1M 0.22%
269,172
-2,309
-0.9% -$270K
BLD
111
DELISTED
TopBuild
BLD
$32M 0.22%
204,691
+950
+0.5% +$151K
AZO icon
112
AutoZone
AZO
$50.2B
$31.6M 0.21%
12,811
-832
-6% -$2.01M
CRWD icon
113
CrowdStrike
CRWD
$183B
$31.1M 0.21%
1,180,676
+386,300
+49% +$13.2M
PLD icon
114
Prologis
PLD
$137B
$31M 0.21%
275,190
-141,923
-34% -$15.7M
UDR icon
115
UDR
UDR
$12.8B
$30.3M 0.2%
783,265
+543,477
+227% +$21.5M
JPM icon
116
JPMorgan Chase
JPM
$947B
$30.3M 0.2%
226,097
-139,972
-38% -$17.7M
KROS icon
117
Keros Therapeutics
KROS
$202M
$30.1M 0.2%
625,914
+264,125
+73% +$12.3M
TTEK icon
118
Tetra Tech
TTEK
$8.28B
$29.7M 0.2%
1,021,335
-114,845
-10% -$3.32M
ITW icon
119
Illinois Tool Works
ITW
$81.9B
$29.5M 0.2%
133,899
-168,186
-56% -$35.8M
BALL icon
120
Ball Corp
BALL
$17.2B
$29.3M 0.2%
573,852
-56,745
-9% -$2.94M
BBY icon
121
Best Buy
BBY
$18.6B
$29.2M 0.2%
364,204
-46,222
-11% -$3.4M
SQM icon
122
Sociedad Química y Minera de Chile
SQM
$19.6B
$29.1M 0.2%
364,439
-101,629
-22% -$9.41M
XENE icon
123
Xenon Pharmaceuticals
XENE
$6.36B
$29M 0.2%
735,884
-25,000
-3% -$910K
CNC icon
124
Centene
CNC
$31.6B
$28.9M 0.19%
352,111
-3,189
-0.9% -$260K
IBM icon
125
IBM
IBM
$204B
$28.7M 0.19%
203,899
+30,903
+18% +$4.26M

Similar funds

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.